TLR3 Activation Impairs Dengue Virus Replication
Author Information
Author(s): Liang Zhao, Wu Siyu, Li Yuye, He Li, Wu Minhao, Jiang Lifang, Feng Lianqiang, Zhang Ping, Huang Xi
Primary Institution: Sun Yat-sen University, Guangzhou, China
Hypothesis
Does activation of Toll-Like Receptor 3 (TLR3) impair the replication of Dengue Virus Serotype 2 (DENV2) in hepatoma cells?
Conclusion
The study found that TLR3 activation significantly reduces DENV2 replication through the induction of IFN-β.
Supporting Evidence
- TLR3 ligand poly(I∶C) treatment significantly down-regulated DENV2 replication.
- Pretreatment with poly(I∶C) reduced viral mRNA expression and the number of viral positive cells.
- Neutralization of IFN-β restored DENV2 replication that was inhibited by poly(I∶C).
- The protective effect of TLR3 activation was dependent on the timing of treatment.
Takeaway
When certain cells are treated with a special substance before getting infected with the dengue virus, it helps stop the virus from making more copies of itself.
Methodology
HepG2 hepatoma cells were treated with TLR ligands and then infected with DENV2 to assess viral replication.
Limitations
The study primarily focused on a single cell line and may not fully represent the immune response in vivo.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website